Q32 Bio Inc.

QTTB | NASDAQ

Price Alert Chart Builder DCF Calculator

$10.47

-$0.07 (-0.66%)

At close: Sep 21, 2026, 4:00 PM ET

$10.93

+$0.46 (+4.39%)

Pre-market: Sep 22, 2026, 8:50 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.66%

(1D)

Rating

Updated: Aug 13, 2026

Fundamentals Excellent

Market Sentiment Bullish

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $311.63M

1D Range

10.35 10.73

52W Range

1.78 23.57

Valuation (TTM)

PE 3.75

PB 2.94

EV/EBITDA 6.06

Valuation (NTM)

Forward PE N/A

Forward PEG 0.13

Price Target $38

Cash Flow

FCF Yield -8.4%

SBC Adj. FCF Yield -10.8%

SBC Impact -28.4%

Margins

Gross Margin 99.8%

Operating Margin 39.9%

FCF Margin -48.7%

Growth (CAGR)

Revenue 3Y | 5Y 71.1% | 10.2%

Dil EPS 3Y | 5Y 143.9% | 32.1%

FCF 3Y | 5Y 7.3% | 30.7%

Returns

ROA 29.2%

ROE 76.9%

ROIC 19.3%

Financial Health

Net Cash

$101.71M

Current Ratio 20.30

Interest Coverage 16.51

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Operating as a clinical-stage biotechnology firm, Q32 Bio Inc. is dedicated to developing biologic therapies aimed at re-establishing healthy immune equilibrium in patients across the United States su...

Sector Healthcare

Industry Biotechnology

Employees 22

IPO Date Mar 27, 2018

Website www.q32bio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$36

Upside

+243.84%

Buy (3)

Hold (0)

Sell (0)

Analyst Details ➞